Head of Research, IPOs & Placements, Aequitas Research

Sumeet Singh

Head of Research, IPOs & Placements

IPOs and Placements coverage across Asia Pacific

Aequitas Research

We cover all listing across the Asia Pacific along with follow-up placements. As of Dec 2020, our team had covered 539 IPOs with a hit rate of 73.5% and 685 placements with a hit rate of 66.8%.

We combine fundamental bottom-up views with our proprietary quantitative framework to provide a holistic coverage across new listings and placements. Our coverage includes pre-IPO notes before the deal is launched, follow-up analysis once the deal is live and post-listing trading analysis as well.

Equity Capital Markets

<ul>
<li>Aequitas Research's weekly update on the IPOs, placements, lockup expiry and other ECM linked events that were covered by the team over the past week.</li>
<li>On the IPO front, Inida ECM flows continued unabated with more deals being launched.</li>
<li>On the placements front as well, India saw over US$2bn worth of deals during the week.</li>
</ul>


Aequitas Research's weekly update on the IPOs, placements, lockup expiry and other ECM linked events that were covered by the team over the past week.
On the IPO front, Inida ECM flows continued unabated with more deals being launched.
On the placements front as well, India saw over US$2bn worth of deals during the week.


ECM Weekly (11 August 2025)-Bharti, Eternal, Paytm, LG CNS, Guming, JSW, Bluestone, SICC, Roborock

APAC IPOs & Placements, Aequitas Research

Akshat Shah

APAC IPOs & Placements

Dr Agarwal's Health Care Ltd / Equity Capital Markets

<ul>
<li>
<a href="https://www.smartkarma.com/entities/dr-agarwal-s-health-care-ltd" target="_blank" data-smartkarma-citation="entities:43984:1" rel="noopener">Dr Agarwal's Health Care Ltd (8140044Z IN)</a> raised around US$350m in its India IPO in Jan 2025. The lockup on its pre-IPO investors is set to expire soon.</li>
<li>Dr Agarwal’s Health Care is a healthcare/hospital chain in India providing eyecare services, including surgeries; consultations, diagnoses, non-surgical treatments; and sells opticals, contact lens, accessories and eyecare related pharmaceutical products.</li>
<li>In this note, we will talk about the lockup dynamics and possible placement.</li>
</ul>



Dr Agarwal's Health Care Ltd (8140044Z IN) raised around US$350m in its India IPO in Jan 2025. The lockup on its pre-IPO investors is set to expire soon.
Dr Agarwal’s Health Care is a healthcare/hospital chain in India providing eyecare services, including surgeries; consultations, diagnoses, non-surgical treatments; and sells opticals, contact lens, accessories and eyecare related pharmaceutical products.
In this note, we will talk about the lockup dynamics and possible placement.


Dr Agarwal’s Health Care IPO Lockup - US$725m Lockup Release; PE Investors May Look to Cash Out

India Equity Analyst - Fundamental & Thematic, Beat the Street

Sudarshan Bhandari

India Equity Analyst - Fundamental & Thematic

Beat the Street

Beat The Street was founded by Nimish Maheshwari and Sudarshan Bhandari, both of whom are Chartered Accountants by Profession, known for their expert analysis in the fields of Business, Sectoral analysis, and Corporate governance.

With a strong social media presence of 45,000+ Subscribers across various platforms, they are considered trusted voices in the industry. Their insights and analysis have been featured in some of India’s most prominent publications, including the Economic Times, Dalal Street Investment Journal, The Morning Context, and The Ken.

Their analysis on Bankrupt & Insolvent companies has been instrumental in saving investors from significant losses. They have a keen eye for identifying red flags and has identified exclusive redflags earlier in Vedanta, Nykaa, Dhani Services, Adani and many more.

Read Business Not Stock Prices

Thematic (Sector/Industry)

<ul>
<li>Since 2021, coffee prices have surged up to 300%, driven by supply disruptions in major producers like Brazil and Vietnam. Recent price corrections provides relief still volatility remains high. </li>
<li>The price fluctuations directly affect Indian coffee processors, with increased working capital requirements and lower PAT margin. Stabilizing prices can improve profitability and working capital cycles. </li>
<li>
FMCG giants like Nestle and Tata Consumer Products faced margin pressures due to volatile coffee prices. While recent declines provide relief, continued price uncertainty requires adaptive strategies for cost management.</li>
</ul>


Since 2021, coffee prices have surged up to 300%, driven by supply disruptions in major producers like Brazil and Vietnam. Recent price corrections provides relief still volatility remains high. 
The price fluctuations directly affect Indian coffee processors, with increased working capital requirements and lower PAT margin. Stabilizing prices can improve profitability and working capital cycles. 

FMCG giants like Nestle and Tata Consumer Products faced margin pressures due to volatile coffee prices. While recent declines provide relief, continued price uncertainty requires adaptive strategies for cost management.


Thematic Report on the Coffee Price Rollercoaster: Implications for India’s FMCG & Processing Sector

HDB Financial Services Ltd / Equity Capital Markets

<ul>
<li>
<a href="https://www.smartkarma.com/entities/hdb-financial-services-ltd" target="_blank" data-smartkarma-citation="entities:44072:1" rel="noopener">HDB Financial Services</a> (HDBFS) raised around US$1.4bn in its India IPO.</li>
<li>HDBFS is a leading retail-focused non-banking financial company (NBFC) in India, in terms of total gross loan book size, according to the CRISIL Report.</li>
<li>We have looked at the past performance and pricing in our previous note. In this note, we talk about the trading dynamics.</li>
</ul>



HDB Financial Services (HDBFS) raised around US$1.4bn in its India IPO.
HDBFS is a leading retail-focused non-banking financial company (NBFC) in India, in terms of total gross loan book size, according to the CRISIL Report.
We have looked at the past performance and pricing in our previous note. In this note, we talk about the trading dynamics.


HDB Financial Services IPO Trading - Strong Demand, Driven by Instis

<ul>
<li>India ranks third globally in power generation growth, with 83% of investment in clean energy and strong foreign interest driven by supportive government policies.</li>
<li>McKinsey projects India could unlock USD 2 trillion across 18 high-growth sectors by 2030, potentially contributing 30 percent to incremental GDP by 2040.</li>
<li>
<a href="https://www.smartkarma.com/entities/tata-consumer-products" target="_blank" data-smartkarma-citation="entities:258:1" rel="noopener">Tata Consumer Products (TATACONS IN)</a> is embedding AI across operations to drive speed, precision, and hyper personalised engagement, signaling a bold digital pivot to redefine its FMCG growth trajectory.</li>
</ul>


India ranks third globally in power generation growth, with 83% of investment in clean energy and strong foreign interest driven by supportive government policies.
McKinsey projects India could unlock USD 2 trillion across 18 high-growth sectors by 2030, potentially contributing 30 percent to incremental GDP by 2040.

Tata Consumer Products (TATACONS IN) is embedding AI across operations to drive speed, precision, and hyper personalised engagement, signaling a bold digital pivot to redefine its FMCG growth trajectory.


#165 India Insights: India’s Clean Power Surge, $2T Growth Outlook, Tata Consumer Bets on AI

India

Tata Consumer Products Limited produces food and beverage products. The Company manufactures, sells, and exports tea, coffee, salt, oil, pulses, spices, and food products. Tata Consumer Products serves customers worldwide.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Tata Consumer Products (TATACONS IN)

ECM Weekly (11 August 2025)-Bharti, Eternal, Paytm, LG CNS, Guming, JSW, Bluestone, SICC, Roborock

Aequitas Research's weekly update on the IPOs, placements, lockup expiry and other ECM linked events that were covered by the team over the past week.

Sumeet Singh

Dr Agarwal’s Health Care IPO Lockup - US$725m Lockup Release; PE Investors May Look to Cash Out

Dr Agarwal’s Health Care (DAH) raised around US$350m in its India IPO in Jan 2025. The lockup on its pre-IPO investors is set to expire soon.

Akshat Shah

Thematic Report on the Coffee Price Rollercoaster: Implications for India’s FMCG & Processing Sector

Coffee prices have dropped 25% since last 3 months, impacting Indian processors and FMCG giants. Stabilizing prices crucial for profitability and...

Sudarshan Bhandari

HDB Financial Services IPO Trading - Strong Demand, Driven by Instis

HDB Financial Services (HDBFS) raised around US$1.4bn in its India IPO. In this note, we talk about the trading dynamics.

Sumeet Singh

#165 India Insights: India’s Clean Power Surge, $2T Growth Outlook, Tata Consumer Bets on AI

India's strong growth in clean energy and government support could lead to significant economic gains, while Tata Consumer Products is embracing...

Sudarshan Bhandari

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)

ECM Weekly (11 August 2025)-Bharti, Eternal, Paytm, LG CNS, Guming, JSW, Bluestone, SICC, Roborock

Aequitas Research's weekly update on the IPOs, placements, lockup expiry and other ECM linked events that were covered by the team over the past week.

Sumeet Singh

Dr Agarwal’s Health Care IPO Lockup - US$725m Lockup Release; PE Investors May Look to Cash Out

Dr Agarwal’s Health Care (DAH) raised around US$350m in its India IPO in Jan 2025. The lockup on its pre-IPO investors is set to expire soon.

Akshat Shah

Thematic Report on the Coffee Price Rollercoaster: Implications for India’s FMCG & Processing Sector

​Coffee prices have dropped 25% since last 3 months, impacting Indian processors and FMCG giants. Stabilizing prices crucial for profitability and...

Sudarshan Bhandari

HDB Financial Services IPO Trading - Strong Demand, Driven by Instis

HDB Financial Services (HDBFS) raised around US$1.4bn in its India IPO. In this note, we talk about the trading dynamics.

Sumeet Singh

#165 India Insights: India’s Clean Power Surge, $2T Growth Outlook, Tata Consumer Bets on AI

​India's strong growth in clean energy and government support could lead to significant economic gains, while Tata Consumer Products is embracing...

Sudarshan Bhandari

Coffee prices have dropped 25% since last 3 months, impacting Indian processors and FMCG giants. Stabilizing prices crucial for profitability and...

India's strong growth in clean energy and government support could lead to significant economic gains, while Tata Consumer Products is embracing...